These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6323421)

  • 81. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
    Estry DW; Tishkoff GH
    Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification of novel glycosylation events on human serum-derived factor IX.
    Pegg CL; Zacchi LF; Recinos DR; Howard CB; Schulz BL
    Glycoconj J; 2020 Aug; 37(4):471-483. PubMed ID: 32378017
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Quantification of contact system activation using a radiometric assay for activated factor IX.
    Berkowitz RM; Nemerson Y
    Blood; 1980 Mar; 55(3):528-31. PubMed ID: 6444531
    [No Abstract]   [Full Text] [Related]  

  • 84. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
    Avdonin PP; Blinova MS; Generalova GA; Emirova KM; Avdonin PV
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254639
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An alternative approach to somatic cell gene therapy.
    St Louis D; Verma IM
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3150-4. PubMed ID: 3283738
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence.
    Choo KH; Raphael K; McAdam W; Peterson MG
    Nucleic Acids Res; 1987 Feb; 15(3):871-84. PubMed ID: 3029708
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.
    Armentano D; Thompson AR; Darlington G; Woo SL
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6141-5. PubMed ID: 2385589
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enzymatic removal of sialic acid from human factor IX and factor X has no effect on their coagulant activity.
    Bharadwaj D; Harris RJ; Kisiel W; Smith KJ
    J Biol Chem; 1995 Mar; 270(12):6537-42. PubMed ID: 7896789
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Proteolytic processing of human coagulation factor IX by plasmin.
    Samis JA; Ramsey GD; Walker JB; Nesheim ME; Giles AR
    Blood; 2000 Feb; 95(3):943-51. PubMed ID: 10648407
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Blood clotting factor IX. Loss of activity after cleavage of sialic acid residues.
    Chavin SI; Weidner SM
    J Biol Chem; 1984 Mar; 259(6):3387-90. PubMed ID: 6323421
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.